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Abstract
The objective of this study was to investigate an interaction between nematodes and gut Enterobacteriaceae
that use benzimidazoles as a carbon source. By addressing this objective, we identified an anthelmintic
resistance-like mechanism for gastrointestinal nematodes. We isolated 30 gut bacteria (family
Enterobacteriaceae) that subsist on and putatively catabolize benzimidazole-class anthelmintics. C. elegans
was protected from the effects of benzimidazoles when co-incubated with these Enterobacteriaceae that also
protect adult ascarids from the effects of albendazole. This bacterial phenotype represents a novel mechanism
by which gastrointestinal nematodes are potentially spared from the effects of benzimidazoles, without any
apparent fitness cost to the parasite.
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Abstract
The objective of this study was to investigate an interaction between nematodes and gut Enterobacteriaceae that
use benzimidazoles as a carbon source. By addressing this objective, we identified an anthelmintic resistance-like
mechanism for gastrointestinal nematodes. We isolated 30 gut bacteria (family Enterobacteriaceae) that subsist on
and putatively catabolize benzimidazole-class anthelmintics. C. elegans was protected from the effects of
benzimidazoles when co-incubated with these Enterobacteriaceae that also protect adult ascarids from the effects of
albendazole. This bacterial phenotype represents a novel mechanism by which gastrointestinal nematodes are
potentially spared from the effects of benzimidazoles, without any apparent fitness cost to the parasite.
Keywords: Enterobacteriaceae; Nematode; Anthelmintic;
Benzimidazoles
Introduction
Approximately 2 billion people are infected with gastrointestinal
(GI) nematodes worldwide [1]. Benzimidazoles are one of the
preferred drug classes for treating these parasites but, unfortunately,
resistance is emerging [2]. Resistance is conferred, at least in some
instances, by mutations in the nematode genes encoding for tubulin
[3], a cytoskeletal protein targeted for inhibition by benzimidazoles [4].
These mutations alter the benzimidazole-binding site on tubulin
without hampering the function of the cytoskeletal protein [3].
Resistance to anti-infectives is typically based on: altering the target
of the anti-infective (as observed with tubulin alterations and
benzimidazole resistance); creation or utilization of a new or
alternative pathway that circumvents the target of the anti-infective;
efflux of the anti-infective out of the pathogen; or, chemical alteration
of the anti-infective drug. The resistance repertoire of nematodes is
somewhat limited when compared to bacteria since prokaryotes are
capable exhibiting all of these four resistance mechanisms whereas the
resistance of nematodes does not usually include alteration of the drug.
Empirically observed resistance to benzimidazoles has not been
completely associated with tubulin gene mutations [2]. In a previous
study we identified bacteria capable of catabolizing and inactivating
antibiotics [5]. In the current study, we examined this possibility for
bacteria that subsist on benzimidazoles. Furthermore, we investigated
an interaction between nematodes and commensal intestinal bacteria
whereby the bacteria may use benzimidazoles as a carbon source and
the nematode would thereby be protected from the benzimidazoles.
Materials and Methods
The bacteria used in this study included isolates obtained from
various fecal sources including toilet water, canine feces, bovine feces,
feline feces, ovine feces, caprine feces, environmental water, and soil.
Samples were first inoculated in 20 mL of Lennox L broth and then
grown statically overnight at 37°C. An aliquot (100 μL) of the growth
was then plated on XLD agar to partially select for bacteria of the
Enterobacteriaceae family, which are frequent commensals of the
gastrointestinal tract of eukaryotes [6,7].
In our previous studies we assessed the ability of Salmonella, a
member of the Enterobacteriaceae family, to subsist on and putatively
catabolize antibacterial drugs. To do so, we used single-carbon-source
media (SCSM) to assess the ability of the isolates to subsist on a given
antibacterial drug [8]. In the current study we used the same approach
to identify Enterobacteriaceae that subsist on albendazole (Sigma
Aldrich), a model benzimidazole. Specifically, enteric bacteria
(approximately 108 CFUs) from each XLD agar plate were collected en
masse in PBS and transferred onto SCSM-albendazole agar containing
1 μg/mL of the albendazole as per previous studies [5,8]. Bacteria that
grew on the SCSM-albendazole (about 5% of samples yielded growth
within 24 hrs) were transferred to SCSM-mebendazole, SCSM-
fenbendazole, and SCSM-thiabendazole (1 μg/mL of each drug).
Bacteria that grew on SCSM-albendazole were also transferred to XLD
agar and subjected to a PCR and DNA sequencing procedure that
exploits a hypervariable region of 16s rRNA, in order to determine the
genus and species of a candidate Enterobacteriaceae [9].
To determine if the subsistence on benzimidazoles extrapolated to
an inactivation of the drug, adult C. elegans was co-incubated with one
of the four drugs and an Enterobacteriaceae (toilet water E. coli)
capable of subsisting on benzimidazoles. A range of 50-100 adult C.
elegans strain N2 were placed on NGM agar (100 mm plates)
containing 0-200 ng/mL (which includes the estimated range of
intestinal drug concentration) of one of four benzimidazoles. Up to 109
CFUs/mL (which includes the estimated range of intestinal
Enterobacteriaceae concentration) of a benzimidazole-catabolizing E.
coli was co-incubated with the C. elegans. For all C. elegans assays, the
total bacterial concentration was maintained at 109 CFUs/mL by the
addition of the standard food source of E. coli strain OP50 [10]. C.
elegans were maintained at 25°C in the dark and then were
microscopically monitored for movement (or lack thereof) at three
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days after the addition of bacteria [11]. Controls included worms
incubated with non-catabolic isostrains (ATCC), worms not exposed
to a benzimidazole, and worms incubated with a catabolic strain plus
200 ng/mL of albendazole in the presence of ambient light that leads to
the degradation of albendazole [12]. Percent worm viability (i.e.,
percent of worms exhibiting motility during a two minute visualization
period) was then noted for each E. coli-benzimidazole combination.
Statistical differences were examined using an ANOVA with Tukey’s
test for multiple comparisons (GraphPad Prism 6.0). p<0.05 was
considered to be significant.
Results
As shown in Table 1, we isolated 30 different Enterobacteriaceae
capable of subsisting on albendazole. These isolates represent the
following bacteria: E. coli, n=10; Enterobacter aerogenes, n=6;
Klebsiella pneumonia, n=5; Citrobacter koseri, n=4; Providencia
vermicola, n=2; Enterobacter cloacae, n=2; and, Klebsiella oxytoca,
n=1. All 30 isolates were capable of subsisting on each of the four
benzimidazoles examined.
Genus and species Sources of the isolates
E. coli (n=10 isolates) Nigerian environmental water; Bovine feces; Canine feces (n=2); Ovine feces; Caprine feces; Toilet water(Iowa State University); Environmental soil (n=2); Feline feces
Enterobacter aerogenes (n=6 isolates) Equine feces; Feline feces; Bovine feces (n=2); Environmental water
Klebsiella pneumoniae (n=5 isolates) Canine feces (n=3); Bovine feces; Raccoon feces
Citrobacter koseri (n=4 isolates) Canine feces (n=3); Environmental soil
Enterobacter cloacae (n=2 isolates) Feline feces; Canine feces
Providencia vermicola (n=2 isolates) Canine feces; Environmental water
Klebsiella oxytoca (n=1 isolate) Equine feces
Table 1: Identities and sources of bacteria capable of subsisting on benzimidazoles.
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Figure 1: Diminished albendazole effectiveness in C. elegans co-existing with a benzimidazole-catabolizing E. coli. A range of 50-100 adult C.
elegans (average of 73 per assay) were co-incubated with various concentrations (0-109 CFUs/mL) of a benzimidazole-catabolizing E. coli
(toilet water E. coli isolate) (Table 1) and 0-200 ng/mL of albendazole. Total bacteria concentration totalled 109 CFUs/mL by the inclusion of
food strain E. coli strain OP50 (10). Worm activity was then monitored microscopically after 3 days, and % motile worms were calculated.
Data represent the mean + sem for four independent experiments. The following concentrations of bacteria significantly (p<0.05) altered %
motile worms, when compared to worms exposed to no albendazole at the same concentration of bacteria, at the parenthetically designated
concentrations of albendazole: 104 CFUs/mL (200 ng/mL- ambient light); 105 and 106 CFUs/mL (50 ng/mL, 100 ng/mL, 200 ng/mL, and 200
ng/mL- ambient light); 107-109 CFUs/mL (25 ng/mL, 50 ng/mL, 100 ng/mL, 200 ng/mL, and 200 ng/mL- ambient light).
To determine if the subsistence extrapolate to protection for a
nematode, adult C. elegans were co-incubated with various
concentrations of a benzimidazole-catabolizing E. coli and
albendazole. As shown in Figure 1, the benzimidazole-catabolizing E.
coli protected C. elegans from the effects of multiple concentrations of
albendazole, and that the protection afforded by the E. coli was
dependent upon the density of catabolic bacteria co-incubated with C.
elegans. The following concentrations of bacteria significantly (p<0.05)
altered % motile worms, when compared to worms exposed to no
albendazole at the same concentration of bacteria, at the
parenthetically designated concentrations of albendazole: 104
CFUs/mL (200 ng/mL- ambient light); 105 and 106 CFUs/mL (50
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ng/mL, 100 ng/mL, 200 ng/mL, and 200 ng/mL- ambient light);
107-109 CFUs/mL (25 ng/mL, 50 ng/mL, 100 ng/mL, 200 ng/mL, and
200 ng/mL- ambient light). It is of note that maintaining the worms in
ambient light, which degrades albendazole [12], provided protection
from albendazole and this effect was amplified in the presence of
benzimidazole-catabolizing E. coli.
To determine if the observed effect was valid for other
benzimidazoles, adult C. elegans were co-incubated with four different
benzimidazole-catabolizing E. coli (or E. coli OP50) and a
benzimidazole. Worm activity was then monitored microscopically
after 3 days, and % of non-motile worms was calculated. As shown in
Figure 2, the protective effect extended to three other benzimidazoles:
fenbendazole, mebendazole, and thiabendazole. It is of note that the E.
coli are possibly catabolizing the benzimidazoles on NGM agar even
though this media has ample carbon sources for supporting bacterial
growth [10].
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Figure 2: Diminished benzimidazole effectiveness in C. elegans co-incubated with benzimidazole-catabolizing E. coli. A range of 50-100 adult
C. elegans were co-incubated with 107 CFUs/mL (lowest tested concentration of bacteria that consistently altered benzimidazole efficacy at
most drug concentrations tested as shown in Figure 1) of four different benzimidazole-catabolizing E. coli (or E. coli OP50) and 100 ng/mL
(lowest drug concentration leading to the maximal catabolic response) of a benzimidazole. Worm activity was then monitored microscopically
after 3 days, and % of non-motile worms was calculated. Data represent the mean + sem for three independent experiments. *p<0.05 vs. non-
catabolic bacteria and E. coli OP50. For these studies we randomly chose the following E. coli isolate/benzimidazole combinations: Nigerian
water isolate/albendazole; bovine fecal isolate/fenbendazole; ovine fecal isolate/mebendazole; and, a caprine fecal isolate/thiabendazole (Table
1).
To determine if the observed effects extended to adult
gastrointestinal nematodes, adult ascarids were obtained from swine
and monitored at least every 12 hrs for activity following the addition
of albendazole plus a benzimidazole-catabolizing E. coli. Figure 3
reveals that the catabolic bacteria were able to protect swine-derived
intestinal ascarids from albendazole. For these studies, ascarids were
obtained from swine and incubated with 65 ng/mL of albendazole and
a 107 CFUs/mL of catabolic bacterium in liquid media. The catabolic
bacteria more than doubled the time required for albendazole to
immobilize, as determined by visualize inspection for complete lack of
movement over a two minute period, 100% of a population of adult
nematodes obtained from the gastrointestinal tract of a mammal.
Discussion
Herein we report a phenomenon in which gut Enterobacteriaceae
are capable of subsisting on benzimidazoles, an effect that provides a
passive benzimidazole resistance-like mechanism to free-living and
gastrointestinal nematodes living in proximity to the bacteria. This
study does not uncover the mechanisms underlying the phenomenon,
but it does bring forth the possibility of an emerging problem with
benzimidazole failures. That is, this study brings forth the possibility of
a new mechanism for treatment failures in gastrointestinal nematodes.
The bacteria isolated were obtained from various fecal sources,
including the developing world where gastrointestinal nematodes are
more prevalent [13]. Our studies suggest that benzimidazole-
insensitive nematodes could appear in intestinal tracts in which the
parasite co-exists with commensal Enterobacteriaceae exhibiting the
catabolic phenotype. A number of studies have established that
Enterobacteriaceae interact with gastrointestinal nematodes, either by
living in proximity to the nematode [14] or by physically interacting
with the nematode [15]. Additionally, we could find no studies
identifying an antagonism between Enterobacteriaceae and
gastrointestinal nematodes. Therefore, this relationship does not
appear to compromise the fitness of the nematode. However, the initial
studies presented herein do not identify a dramatic benefit for the
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bacteria and thus the effect will disappear when the bacteria are no
longer near the nematode.
In summary, this is the first report of a phenomenon in which
commensal gut bacteria catabolize benzimidazoles and thus potentially
protect local nematodes from the effects of the drugs. Fortunately, this
phenomenon has an intervention point that can be pharmacologically
targeted. The catabolism-conferring enzymes, once identified, could be
pharmacologically inhibited without instigating an adaptive response
by the bacteria. That is, the catabolism-conferring enzymes do not
appear to be vital for the bacteria and thus inhibiting these enzymes
will not induce any selection pressure upon the catabolic bacteria.
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Figure 3: Diminished benzimidazole effectiveness in ascarids co-incubated with a benzimidazole-catabolizing E. coli. Adult ascarids were
obtained from swine at a commercial abattoir (as previously described by (16)), maintained in RPMI/FBS (Difco; which supports ascarids (17)
and the Enterobacteriaceae (18)), and monitored at least every 12 hrs for activity following the addition of albendazole plus a benzimidazole-
catabolizing E. coli. Specifically, four to five adult worms were incubated with 107 CFUs/mL (i.e., the lowest tested bacterial concentration that
consistently altered the efficacy of albendazole as per Figure 1) of one of the benzimidazole-catabolizing E. coli (toilet water isolate). Media
contained 65ng/mL of albendazole, i.e., the approximated albendazole EC50 in the absence of catabolic bacteria as per Figure 1. A control
group entailed worms, 65 ng/mL albendazole, and 107 CFUs/mL of non-catabolic bacteria (E. coli OP50). Media (including bacteria and
drugs) were replenished daily and worm activity was monitored every 12 hr. Time points were recorded in which 100% of the worms were
immobile. Values derived are means + sem from assays performed on five different occasions, with fresh batches of worms used each time.
*p<0.05 vs. catabolic bacteria (E. coli toilet water isolate).
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